在药物耐药性突变率不同时,最佳的抗微生物剂量组合.
Oscar Delaney1, Andrew D Letten1, Jan Engelstädter1
1School of the Environment, The University of Queensland, St Lucia, Queensland, Australia.
概括
优化抗微生物药物组合对于对抗耐药性至关重要. 了解细菌突变率揭示了理想药物比率的功率规律关系,可能提高治疗成功率.
科学领域:
- 微生物学 微生物学
- 药理学 药理学 是一个学科.
- 数学生物学 数学生物学
背景情况:
- 抗微生物药物耐药性 (AMR) 的不断升级的危机需要新的策略来防止耐药性细菌菌株的出现.
- 在不同药物类别中,赋予抗微生物耐药性的细菌突变率在不同药物类别中存在显著差异.
研究的目的:
- 调查相对突变率的知识是否可以优化两种抗微生物药物的联合剂量.
- 确定统治最佳药物比率的数学关系,以最大限度地提高治疗成功率,同时最大限度地减少耐药性演变.
主要方法:
- 开发和应用数学模型来模拟不同药物组合场景下的细菌进化.
- 使用计算机模拟来探索不同突变率对治疗结果的影响.
主要成果:
- 在最佳药物A:药物B剂量比率和它们的突变率的比率之间,在日志-日志空间中确定了显著的线性关系.
- 发现这种功率定律关系对于细菌静止剂和杀菌剂抗微生物剂都是一致的.
- 这些发现表明,相对突变率是确定最佳组合疗法方案的关键因素.
结论:
- 相对突变率为优化抗微生物组合治疗提供了可量化的基础.
- 识别的功率定律关系为设计更有效的抗菌剂剂量策略提供了预测工具.
- 这些发现的经验验证可能会导致临床治疗方案的实质性改进,并打击AMR.
相关概念视频
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Dosage Interval and Administration Route: Determination Methods
227
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
227
Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Estimation of k and VD of Aminoglycosides
214
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
214


